Anti-CCP antibodies and bone
- PMID: 29636111
- PMCID: PMC5894147
- DOI: 10.1186/s13075-018-1566-3
Anti-CCP antibodies and bone
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
The authors give consent to the publication.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Comment on
-
Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture.Arthritis Res Ther. 2018 Jan 30;20(1):16. doi: 10.1186/s13075-018-1515-1. Arthritis Res Ther. 2018. PMID: 29382355 Free PMC article.
References
-
- Bugatti S, Bogliolo L, Vitolo B, Manzo A, Montecucco C, Caporali R. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):226. doi: 10.1186/s13075-016-1116-9. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources